Last A$0.45 AUD
Change Today -0.02 / -4.30%
Volume 481.8K
UNS On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Stuttgart
As of 2:10 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

unilife corp-cdi (UNS) Snapshot

Open
A$0.45
Previous Close
A$0.47
Day High
A$0.46
Day Low
A$0.44
52 Week High
03/20/14 - A$1.05
52 Week Low
08/13/14 - A$0.40
Market Cap
276.6M
Average Volume 10 Days
640.0K
EPS TTM
--
Shares Outstanding
621.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for UNILIFE CORP-CDI (UNS)

Related News

No related news articles were found.

unilife corp-cdi (UNS) Related Businessweek News

View More BusinessWeek News

unilife corp-cdi (UNS) Details

Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics. It also provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. In addition, the company offers the Ocu-ject, a device for the delivery of microliter sized doses of drugs; and Depot-ject, a device that is designed to enable the precise placement of a drug depot into the vitreous of the eye, as well as Micro-ject, a device for optimizing the delivery of drugs with microliter doses that are unsuited to conventional device technologies. Its customers include pharmaceutical and biotechnology companies. The company is headquartered in York, Pennsylvania.

209 Employees
Last Reported Date: 08/29/14

unilife corp-cdi (UNS) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $630.0K
President and Chief Operating Officer
Total Annual Compensation: $511.5K
Vice President of Legal Affairs
Total Annual Compensation: $321.6K
Vice President of Corporate Quality & Regulat...
Total Annual Compensation: $266.8K
Compensation as of Fiscal Year 2013.

unilife corp-cdi (UNS) Key Developments

Unilife Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2014; Provides Earnings Guidance for the Fiscal Year 2015

Unilife Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2014. For the quarter, the company reported revenue of $6,546,000 against $667,000 reported in the same period a year ago. Operating loss was $14,374,000 against $21,641,000 reported last year. Net loss was $15,263,000 or $0.15 per basic and diluted share against $21,977,000 or $0.25 per basic and diluted share reported last year. Adjusted net loss was $11,719,000 or $0.12 per basic and diluted share against $9,864,000 or $0.11 per basic and diluted share reported. For the year, the company reported adjusted net loss was $38,772,000 or $0.40 per basic and diluted share against $38,032,000 or $0.47 per basic and diluted share reported in the same period a year ago. Net operating cash flow loss improved 20% from the year before despite a significant increase in R&D investment in response to growing customer demand. During fiscal year 2015, the company look forward to achieving significant growth in revenue via commercial sales, customization fees and upfront payments from a multitude of customers and active programs. In parallel, the company expects to increase capital expenditures in response to growing customer demand while moderating investments in R&D and keeping SG&A largely stable. Furthermore, the company expects to narrow its operating income loss and operating cash flow loss at an attractive trend during fiscal year 2015.

Unilife Corporation to Report Q4, 2014 Results on Sep 09, 2014

Unilife Corporation announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Sep 09, 2014

Unilife Corporation, Q4 2014 Earnings Call, Sep 09, 2014

Unilife Corporation, Q4 2014 Earnings Call, Sep 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UNS:AU A$0.45 AUD -0.02

UNS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $114.06 USD +0.35
Insulet Corp $32.94 USD -1.93
Terumo Corp ¥2,565 JPY +1.00
West Pharmaceutical Services Inc $43.37 USD -0.25
Ypsomed Holding AG SFr.82.00 CHF +0.10
View Industry Companies
 

Industry Analysis

UNS

Industry Average

Valuation UNS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.5x
Price/Book 41.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNILIFE CORP-CDI, please visit www.unilife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.